SCHEMBL24671500

SCHEMBL24671500

CC(C)(C)OC(=O)N1CCN(CC2CCN(CO)CC2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.44
CNR1 P21554 1/20 0.44
HPGD P15428 1/20 0.43
KDM4E B2RXH2 1/20 0.43
PKM P14618 1/20 0.43
USP2 O75604 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ALDH1A1 P00352 2/20 0.42
RECQL P46063 1/20 0.42
EPHX1 P07099 1/20 0.42
CHRM2 P08172 1/20 0.41
CHRM4 P08173 1/20 0.41
CHRM1 P11229 1/20 0.41
CHRM3 P20309 1/20 0.41
NPC1 O15118 1/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20873854 0.91 HPGD (0.51) NR1H2CNR1HPGDKDM4EPKM
SCHEMBL1100404 0.90 CNR1 (0.51) NR1H2CNR1HPGDKDM4EPKM
SCHEMBL20873836 0.90 CNR1 (0.51) NR1H2CNR1HPGDKDM4EPKM
SCHEMBL5573169 0.90 HPGD (0.53) NR1H2CNR1HPGDKDM4EPKM
SCHEMBL24745371 0.89 CNR1 (0.45) NR1H2CNR1HPGDKDM4EPKM
SCHEMBL27308696 0.89 CACNA2D1 (0.47) NR1H2CNR1HPGDKDM4EPKM
SCHEMBL20046379 0.89 CNR1 (0.44) NR1H2CNR1HPGDKDM4EPKM
SCHEMBL29928185 0.87 NR1H2 (0.56) NR1H2CNR1HPGDKDM4EPKM
SCHEMBL25133786 0.87 NR1H2 (0.56) NR1H2CNR1HPGDKDM4EPKM
SCHEMBL27432720 0.87 CACNA2D1 (0.48) NR1H2CNR1HPGDKDM4EPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022235715-A1 COMPOUNDS FOR INHIBITING OR DEGRADING ITK, COMPOSITIONS, COMPRISING THE SAME METHODS OF THEIR MAKING AND METHODS OF THEIR USE NURIX THERAPEUTICS, INC. (US) 2022-11-10 WO disclosed